July 20, 2018

Trial to assess feasibility, safety of CAR T-cell therapy for relapsed pediatric central nervous system tumors

A clinical trial is underway to examine the role of chimeric antigen receptor T-cell therapy for children and young adults with relapsed or refractory HER-2-positive central nervous system tumors.
March 28, 2018

The Top Doctors in Seattle for 2018

Health care is becoming increasingly complex—and remarkable. Research is unlocking more and more secrets about the human body, and conditions that were at one time hopeless have hopeful prognoses today thanks to new therapies.
March 11, 2018

Trial to assess dual CAR T-cell therapy for children, young adults with leukemia

A trial is underway to evaluate the use of dual chimeric antigen receptor T-cell immunotherapy for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia.
February 6, 2018

In the future, cancer treatment may be remote controlled

In the future, fighting cancer may no longer mean grueling chemotherapy, but genetically altered immune systems that can be “remote controlled.”